Metabolic and Endocrine Neuropathies

  • Beth B. Murinson
  • Vinay Chaudhry


Metabolic and endocrine neuropathies, although generally well characterized clinically and electrophysiologically, represent an area in which improved mechanistic understanding is still needed. Although in most cases early detection and reversal of underlying abnormalities is the most effective therapeutic intervention, there are clinical states where metabolic abnormalities may persist for decades without complete resolution, e.g., chronic renal or hepatic failure in the absence of transplantation. In these instances, there remains a compelling clinical impetus for scientific advances in this area.

In this chapter, we discuss the clinical manifestations, electrophysiological findings, presumed pathogenesis, treatment options, and prognosis of peripheral neuropathy associated with renal failure, hepatic disease, thyroid dysfunction, and pituitary (acromegaly) dysfunction.


Hepatic neuropathy uremic neuropathy hypothyroid neuropathy acromegaly 


  1. 1.
    Comi G, Corbo M. Metabolic neuropathies. Curr Opin Neurol. 1998;11:523–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Perkins AT, Morgenlander JC. Endocrinologic causes of peripheral neuropathy. Pins and needles in a stocking-and-glove pattern and other symptoms. Postgrad Med. 1997;102:81–2, 90–2, 102–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Schaumburg HH, Berger AR, Thomas PK. Disorders of peripheral nerve. 2nd ed. Philadelphia: F.A. Davis; 1992.Google Scholar
  4. 4.
    Said G, Boudier L, Selva J, Zingraff J, Drueke T. Different patterns of uremic polyneuropathy: clinicopathologic study. Neurology. 1983;33:567–74.PubMedCrossRefGoogle Scholar
  5. 5.
    Bolton CF. Peripheral neuropathies associated with chronic renal failure. Can J Neurol Sci. 1980;7:89–96.PubMedGoogle Scholar
  6. 6.
    Appenzeller O, Kornfeld M, MacGee J. Neuropathy in chronic renal disease. A microscopic, ultrastructural, and biochemical study of sural nerve biopsies. Arch Neurol. 1971;24:449–61.PubMedCrossRefGoogle Scholar
  7. 7.
    Asbury AK, Victor M, Adams RD. Uremic polyneuropathy. Arch Neurol. 1963;8:413–28.PubMedCrossRefGoogle Scholar
  8. 8.
    Thomas PK. Screening for peripheral neuropathy in patients treated by chronic hemodialysis. Muscle Nerve. 1978;1:396–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Chao CC, Wu VC, Tan CH, Wang YM, Tseng MT, Wu PC, et al. Skin denervation and its clinical significance in late-stage chronic kidney disease. Arch Neurol. 2011;68(2):200–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Ropper AH. Accelerated neuropathy of renal failure. Arch Neurol. 1993;50:536–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Callaghan N. Restless legs syndrome in uremic neuropathy. Neurology. 1966;16:359–61.PubMedCrossRefGoogle Scholar
  12. 12.
    Fraser CL, Arieff AI. Nervous system complications in uremia. Ann Intern Med. 1988;109:143–53.Google Scholar
  13. 13.
    Solders G, Persson A, Gutierrez A. Autonomic dysfunction in non-diabetic terminal uraemia. Acta Neurol Scand. 1985;71:321–7.PubMedGoogle Scholar
  14. 14.
    Heidbreder E, Schafferhans K, Heidland A. Disturbances of peripheral and autonomic nervous system in chronic renal failure: effects of hemodialysis and transplantation. Clin Nephrol. 1985;23(5):222–8.PubMedGoogle Scholar
  15. 15.
    Mallamaci F, Zoccali C, Ciccarelli M, Briggs JD. Autonomic function in uremic patients treated by hemodialysis or CAPD and in transplant patients. Clin Nephrol. 1986;25(4):175–80.PubMedGoogle Scholar
  16. 16.
    Zoccali C, Ciccarelli M, Mallamaci F, Maggiore Q. Parasympathetic function in haemodialysis patients. Nephron. 1986;44(4):351–4.PubMedCrossRefGoogle Scholar
  17. 17.
    Klein C, Halevy A, Gandelman-Marton R, Halpern Z, Weissgarten J, Averbukh Z, et al. Nerve conduction abnormalities in the arms of patients with arteriovenous fistula. Ren Fail. 1996;18:85–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Knezevic W, Mastaglia FL. Neuropathy associated with brescia-cimino arteriovenous fistulas. Arch Neurol. 1984;41:1184–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Bolton CF, Driedger AA, Lindsay RM. Ischaemic neuropathy in uraemic patients caused by bovine arteriovenous shunt. J Neurol Neurosurg Psychiatry. 1979;42:810–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg. 2004;107(1):1–16.PubMedCrossRefGoogle Scholar
  21. 21.
    Laaksonen S, Metsärinne K, Voipio-Pulkki LM, Falck B. Neuro­physiologic parameters and symptoms in chronic renal failure. Muscle Nerve. 2002;25(6):884–90.PubMedCrossRefGoogle Scholar
  22. 22.
    Bolton CF. Electrophysiologic changes in uremic neuropathy after successful renal transplantation. Neurology. 1976;26:152–61.PubMedCrossRefGoogle Scholar
  23. 23.
    Hansen S, Ballantyne JP. A quantitative electrophysiological study of uraemic neuropathy. Diabetic and renal neuropathies compared. J Neurol Neurosurg Psychiatry. 1978;41(2):128–34.PubMedCrossRefGoogle Scholar
  24. 24.
    Nielsen VK. The peripheral nerve function in chronic renal failure. VI. The relationship between sensory and motor nerve conduction and kidney function, azotemia, age, sex, and clinical neuropathy. Acta Med Scand. 1973;194:455–62.PubMedCrossRefGoogle Scholar
  25. 25.
    Stamboulis E, Voumvouraki K, Zambelis T, Andrikopoulou A, Vlahakos D, Tsivgoulis A, et al. There is no association between ­cardiovascular autonomic dysfunction and peripheral neuropathy in chronic hemodialysis patients. J Clin Neurol. 2010;6(3):143–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Angus-Leppan H, Burke D. The function of large and small nerve fibers in renal failure. Muscle Nerve. 1992;15(3):288–94.PubMedCrossRefGoogle Scholar
  27. 27.
    Dyck PJ, Johnson WJ, Lambert EH, O’Brien PC. Segmental demyelination secondary to axonal degeneration in uremic neuropathy. Mayo Clin Proc. 1971;46:400–31.PubMedGoogle Scholar
  28. 28.
    Milutinovic J, Babb AL, Eschbach JW, Follette WC, Graefe U, Strand MJ, et al. Uremic neuropathy: evidence of middle molecule toxicity. Artif Organs. 1978;2:45–51.PubMedCrossRefGoogle Scholar
  29. 29.
    Violante F, Lorenzi S, Fusello M. Uremic neuropathy: clinical and neurophysiological investigation of dialysis patients using different chemical membranes. Eur Neurol. 1985;24:398–404.PubMedCrossRefGoogle Scholar
  30. 30.
    Kiernan MC, Walters RJ, Andersen KV, Taube D, Murray NM, Bostock H. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia. Brain. 2002;125:1366–78.PubMedCrossRefGoogle Scholar
  31. 31.
    Krishnan AV, Phoon RK, Pussell BA, Charlesworth JA, Bostock H, Kiernan MC. Altered motor nerve excitability in end-stage kidney disease. Brain. 2005;128:2164–74.PubMedCrossRefGoogle Scholar
  32. 32.
    Krishnan AV, Phoon RK, Pussell BA, Charlesworth JA, Bostock H, Kiernan MC. Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease. Clin Neurophysiol. 2006;117(5):992–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Krishnan AV, Pussell BA, Kiernan MC. Neuromuscular disease in the dialysis patient: an update for the nephrologist. Semin Dial. 2009;22(3):267–78.PubMedCrossRefGoogle Scholar
  34. 34.
    Krishnan AV, Kiernan MC. Neurological complications of chronic kidney disease. Nat Rev Neurol. 2009;5(10):542–51.PubMedCrossRefGoogle Scholar
  35. 35.
    Avram MM, Feinfeld DA, Huatuco AH. Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia. N Engl J Med. 1978;298(18):1000–3.PubMedCrossRefGoogle Scholar
  36. 36.
    Avram MM, Iancu M, Morrow P, Feinfeld D, Huatuco A. Uremic syndrome in man: new evidence for parathormone as a multisystem neurotoxin. Clin Nephrol. 1979;11(2):59–62.PubMedGoogle Scholar
  37. 37.
    Goldstein DA, Chui LA, Massry SG. Effect of parathyroid hormone and uremia on peripheral nerve calcium and motor nerve conduction velocity. J Clin Invest. 1978;62(1):88–93.PubMedCrossRefGoogle Scholar
  38. 38.
    Bolton CF, Baltzan MA, Baltzan RB. Effects of renal transplantation on uremic neuropathy. A clinical and electrophysiologic study. N Engl J Med. 1971;284:1170–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Nielsen VK. Recovery from peripheral neuropathy after renal transplantation. Acta Neurol Scand. 1970;46(Suppl):207.PubMedGoogle Scholar
  40. 40.
    Asbury AK. Recovery from uremic neuropathy. N Engl J Med. 1971;284:1211–2.PubMedCrossRefGoogle Scholar
  41. 41.
    Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med. 1989;321(3):158–63.PubMedCrossRefGoogle Scholar
  42. 42.
    Keswani SC, Leitz GJ, Hoke A. Erythropoietin is neuroprotective in models of HIV sensory neuropathy. Neurosci Lett. 2004;371(2–3):102–5.PubMedCrossRefGoogle Scholar
  43. 43.
    Li X, Gonias SL, Campana WM. Schwann cells express erythropoietin receptor and represent a major target for epo in peripheral nerve injury. Glia. 2005;51(4):254–65.PubMedCrossRefGoogle Scholar
  44. 44.
    Hassan K, Simri W, Rubenchik I, Manelis J, Gross B, Shasha SM, et al. Effect of erythropoietin therapy on polyneuropathy in predialytic patients. J Nephrol. 2003;16(1):121–5.PubMedGoogle Scholar
  45. 45.
    Dayan AD, Williams R. Demyelinating peripheral neuropathy and liver disease. Lancet. 1967;2:133–4.PubMedCrossRefGoogle Scholar
  46. 46.
    Chari VR, Katiyar BC, Rastogi BL, Bhattacharya SK. Neuropathy in hepatic disorders. A clinical, electrophysiological and histopathological appraisal. J Neurol Sci. 1977;31:93–111.PubMedCrossRefGoogle Scholar
  47. 47.
    Knill-Jones RP, Goodwill CJ, Dayan AD, Williams R. Peripheral neuropathy in chronic liver disease: clinical, electrodiagnostic, and nerve biopsy findings. J Neurol Neurosurg Psychiatry. 1972;35:22–30.PubMedCrossRefGoogle Scholar
  48. 48.
    Kardel T, Nielsen VK. Hepatic neuropathy. A clinical and electrophysiological study. Acta Neurol Scand. 1974;50:513–26.PubMedCrossRefGoogle Scholar
  49. 49.
    Seneviratne KN, Peiris OA. Peripheral nerve function in chronic liver disease. J Neurol Neurosurg Psychiatry. 1970;33:609–14.PubMedCrossRefGoogle Scholar
  50. 50.
    Thomas PK. Metabolic neuropathies. In: Auguayo AJ, Karpati G, editors. Current topics in nerve and muscle research. Amsterdam: ExcerptaMedica, 1979, p. 255.Google Scholar
  51. 51.
    Perretti A, Gentile S, Balbi P, Persico M, Caruso G. Peripheral neuropathy in liver cirrhosis. A clinical and electrophysiological study. Ital J Gastroenterol. 1995;27:349–54.PubMedGoogle Scholar
  52. 52.
    Cocito D, Maule S, Paolasso I, Castelli L, Ciaramitaro P, Poglio F, et al. High prevalence of neuropathies in patients with end-stage liver disease. Acta Neurol Scand. 2010;122(1):36–40.PubMedCrossRefGoogle Scholar
  53. 53.
    Chaudhry V, Corse AM, O’Brian R, Cornblath DR, Klein AS, Thuluvath PJ. Autonomic and peripheral (sensorimotor) neuropathy in chronic liver disease: a clinical and electrophysiologic study. Hepatology. 1999;1929:1698–703.CrossRefGoogle Scholar
  54. 54.
    Thuluvath PJ, Triger DR. Autonomic neuropathy and chronic liver disease. Q J Med. 1989;72:737–47.PubMedGoogle Scholar
  55. 55.
    Trevisani F, Sica G, Bernardi M. Autonomic neuropathy in advanced liver disease [letter]. Hepatology. 1996;24:1549.PubMedCrossRefGoogle Scholar
  56. 56.
    Oliver MI, Miralles R, Rubies-Prat J, Navarro X, Espadaler JM, Sola R, et al. Autonomic dysfunction in patients with non-alcoholic chronic liver disease. J Hepatol. 1997;26:1242–8.PubMedCrossRefGoogle Scholar
  57. 57.
    Kempler P, Varadi A, Szalay F. Autonomic neuropathy in liver disease [letter]. Lancet. 1989;2:1332.PubMedCrossRefGoogle Scholar
  58. 58.
    Johnson RH, Robinson BJ. Mortality in alcoholics with autonomic neuropathy. J Neurol Neurosurg Psychiatry. 1988;51:476–80.PubMedCrossRefGoogle Scholar
  59. 59.
    Hendrickse MT, Triger DR. Peripheral and cardiovascular autonomic impairment in chronic liver disease: prevalence and relation to hepatic function. J Hepatol. 1992;16:177–83.PubMedCrossRefGoogle Scholar
  60. 60.
    Hendrickse MT, Thuluvath PJ, Triger DR. Natural history of autonomic neuropathy in chronic liver disease [see comments]. Lancet. 1992;339:1462–4.PubMedCrossRefGoogle Scholar
  61. 61.
    Chopra JS, Samanta AK, Murthy JM, Sawhney BB, Datta DV. Role of porta systemic shunt and hepatocellular damage in the genesis of hepatic neuropathy. Clin Neurol Neurosurg. 1980;82:37–44.PubMedCrossRefGoogle Scholar
  62. 62.
    Midroni G, Bilbao JM. Examination of the peripheral nerve biopsy. In: Midroni G, Bilbao JM, editors. Biopsy diagnosis of peripheral neuropathy. Newton: Butterworth-Heinemann; 1995. p. 119–43.Google Scholar
  63. 63.
    Fullerton PM, Gilliatt RW, Lascelles RG, Morgan-Hughes JA. The relation between fiber diameter and internodal length in chronic neuropathy. J Physiol. 1965;178:26P–8.Google Scholar
  64. 64.
    Asbury A. Hepatic neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, editors. Peripheral neuropathy. 2nd ed. Philadelphia: WB Saunders Co.; 1984. p. 1826–32.Google Scholar
  65. 65.
    Asbury A. Neuropathies with renal failure, hepatic disorders, chronic renal insufficiency, and critical illness. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo J, editors. Peripheral neuropathy. 3rd ed. Philadelphia: W.B. Saunders Co.; 1993. p. 1251–65.Google Scholar
  66. 66.
    Thorner PS, Bilbao JM, Sima AA, Briggs S. Porphyric neuropathy: an ultrastructural and quantitative case study. Can J Neurol Sci. 1981;8:281–7.PubMedGoogle Scholar
  67. 67.
    Becker DM, Kramer S. The neurological manifestations of porphyria: a review. Medicine. 1977;56:411–23. [Review 142 refs].PubMedCrossRefGoogle Scholar
  68. 68.
    Barohn RJ, Sanchez JA, Anderson KE. Acute peripheral neuropathy due to hereditary coproporphyria. Muscle Nerve. 1994;17:793–9.PubMedCrossRefGoogle Scholar
  69. 69.
    Hindfelt B, Holmin T. Experimental porta-caval anastomosis and motor nerve conduction velocity in the rat. J Neurol. 1980;223:171–5.PubMedCrossRefGoogle Scholar
  70. 70.
    Charron L, Peyronnard JM, Marchand L. Sensory neuropathy associated with primary biliary cirrhosis. Histologic and morphometric studies. Arch Neurol. 1980;37:84–7.PubMedCrossRefGoogle Scholar
  71. 71.
    Illa I, Graus F, Ferrer I, Enriquez J. Sensory neuropathy as the initial manifestation of primary biliary cirrhosis [letter]. J Neurol Neurosurg Psychiatry. 1989;52:1307.PubMedCrossRefGoogle Scholar
  72. 72.
    Ng K, Lin CS, Murray NM, Burroughs AK, Bostock H. Conduction and excitability properties of peripheral nerves in end-stage liver disease. Muscle Nerve. 2007;35(6):730–8.PubMedCrossRefGoogle Scholar
  73. 73.
    Lee JH, Jung WJ, Choi KH, Chun MH, Ha SB, Lee SK. Nerve conduction study on patients with severe liver syndrome and its change after transplantation. Clin Transplant. 2002;16(6):430–2.PubMedCrossRefGoogle Scholar
  74. 74.
    McDougall AJ, Davies L, McCaughan GW. Autonomic and peripheral neuropathy in endstage liver disease and following liver transplantation. Muscle Nerve. 2003;28(5):595–600.PubMedCrossRefGoogle Scholar
  75. 75.
    Duyff RF, Van Den BJ, Laman DM, van Loon BJ, Linssen WH. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry. 2000;68:750–5.PubMedCrossRefGoogle Scholar
  76. 76.
    Dyck PJ, Lambert EH. Polyneuropathy associated with hypothyroidism. J Neuropathol Exp Neurol. 1970;29:631–58.PubMedCrossRefGoogle Scholar
  77. 77.
    Meier C, Bischoff A. Polyneuropathy in hypothyroidism. Clinical and nerve biopsy study of 4 cases. J Neurol. 1977;215:103–14.PubMedGoogle Scholar
  78. 78.
    Nemni R, Bottacchi E, Fazio R, Mamoli A, Corbo M, Camerlingo M, et al. Polyneuropathy in hypothyroidism: clinical, electrophysiological and morphological findings in four cases. J Neurol Neurosurg Psychiatry. 1987;50:1454–60.PubMedCrossRefGoogle Scholar
  79. 79.
    Duyff RF, Van den Bosch J, Laman DM, van Loon BJ, Linssen WH. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry. 2000;68(6):750–5.PubMedCrossRefGoogle Scholar
  80. 80.
    Fincham RW, Cape CA. Neuropathy in myxedema. A study of sensory nerve conduction in the upper extremities. Arch Neurol. 1968;19:464–6.PubMedCrossRefGoogle Scholar
  81. 81.
    Shirabe T, Tawara S, Terao A, Araki S. Myxoedematous polyneuropathy: a light and electron microscopic study of the peripheral nerve and muscle. J Neurol Neurosurg Psychiatry. 1975;38:241–7.PubMedCrossRefGoogle Scholar
  82. 82.
    Franklyn JA, Boelaert K. Thyrotoxicosis. Lancet. 2012;379(9821):1155–66.PubMedCrossRefGoogle Scholar
  83. 83.
    Lin S. Thyrotoxic periodic paralysis. Mayo Clin Proc. 2005;80(1):99–105.PubMedGoogle Scholar
  84. 84.
    Arimura K, Arimura Y, Ng AR, Sakoda S, Higuchi I. Muscle membrane excitability after exercise in thyrotoxic periodic paralysis and thyrotoxicosis without periodic paralysis. Muscle Nerve. 2007;36(6):784–8.PubMedCrossRefGoogle Scholar
  85. 85.
    Stewart BM. The hypertrophic neuropathy of acromegaly; a rare neuropathy associated with acromegaly. Arch Neurol. 1966;14:107–10.PubMedCrossRefGoogle Scholar
  86. 86.
    Low PA, McLeod JG, Turtle JR, Donnelly P, Wright RG. Peripheral neuropathy in acromegaly. Brain. 1974;97:139–52.PubMedCrossRefGoogle Scholar
  87. 87.
    Dinn JJ, Dinn EI. Natural history of acromegalic peripheral neuropathy. Q J Med. 1985;57:833–42.PubMedGoogle Scholar
  88. 88.
    O’Duffy JD, Randall RV, MacCarty CS. Median neuropathy (carpal-tunnel syndrome) in acromegaly. A sign of endocrine overactivity. Ann Intern Med. 1973;78:379–83.PubMedCrossRefGoogle Scholar
  89. 89.
    Tagliafico A, Resmini E, Nizzo R, Derchi LE, Minuto F, Giusti M, et al. The pathology of the ulnar nerve in acromegaly. Eur J Endocrinol. 2008;159(4):369–73.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of NeurologyJohns Hopkins University School of MedicineBaltimoreUSA
  2. 2.EMG LaboratoryNeurology Outpatient Center, Johns Hopkins HospitalBaltimoreUSA

Personalised recommendations